silybin has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A; Garabadu, D; Geed, M; Krishnamurthy, S | 1 |
| Choi, MS; Jeon, MT; Jung, UJ; Kim, SR | 1 |
2 other study(ies) available for silybin and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Behavior, Animal; Corpus Striatum; Male; Membrane Potential, Mitochondrial; Neurotransmitter Agents; Rats; Silybin; Silymarin | 2014 |
Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-1beta; Microglia; Nerve Degeneration; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Substantia Nigra; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2014 |